Moderna
-$10.75 (-6.19%) Today
-$4.04 (-2.48%) As of 10:11 AM UTC after-hours
Why Robinhood?
You can buy or sell Moderna and other stocks, options, and ETFs commission-free!
About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics.
CEO
Stéphane Bancel
Employees
1,300
Headquarters
Cambridge, Massachusetts
Founded
2010
MRNA Key Statistics
Market Cap
67.13B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
13.80M
High Today
$180.70
Low Today
$156.89
Open Price
$178.30
Volume
18.91M
52 Week High
$189.26
52 Week Low
$46.13
MRNA News
Bloomberg11h
India Drugmaker Warning; Moderna Booster Effective: Virus Update
(Bloomberg) -- Indian drugmakers are warning that halting some cargo flights from China could disrupt the global drug supply chain. China supplies 60% to 70% of
Analyst Ratings
47%
of 17 ratings
Buy
47.1%
Hold
29.4%
Sell
23.5%
MRNA Earnings
-$0.69
$0.34
$1.36
$2.39
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
$2.39 per share
Actual
Available May 6, Pre-Market
